Krankenhaushygiene up2date, Table of Contents Krankenhaushygiene up2date 2014; 09(01): 65-75DOI: 10.1055/s-0034-1364968 Ökonomie und Recht © Georg Thieme Verlag KG Stuttgart · New York Evidence-based Public Health in der Infektionsprävention Thomas Harder Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Sackett DL, Rosenberg WM, Gray JA et al. Evidence based medicine: what it is and what it isn’t. Br Med J 1996; 312: 71-72 (Epub 1996/01/13) 2 Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. Br Med J 1995; 310: 1122-1126 (Epub 1995/04/29) 3 Health Do. What is public health?. 2009 Available from: http://www.dh.gov.uk/en/Aboutus/MinistersandDepartmentLeaders/ChiefMedicalOfficer/Archive/FeaturesArchive/Browsable/DH_5017805 4 Palmer S, Jansen A, Leitmeyer K et al. Evidence-Based Medicine applied to the control of communicable disease incidents when evidence is scarce and the time is limited. Euro surveillance/bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2013; 18 5 Jenicek M. Epidemiology, evidenced-based medicine, and evidence-based public health. J Epidemiology/Japan Epidemiological Association 1997; 7: 187-197 6 Porta M. A dictionary of epidemiology. New York: Oxford University Press; 2008 7 Lomas J, Culyer T, McCutcheon C. Conceptualizing and combining evidence for health system guidance: final report. Ottawa: Canadian Health Services Research Foundation; 2005 8 Methods for the development of NICE public health guidance (third edition). London: National Institute for Health Clinical Excellence; 2012 9 Kelly MP, Stewart E, Morgan A et al. A conceptual framework for public health: NICE’s emerging approach. Public health 2009; 123: e14-2e0 10 Kelly M, Morgan A, Ellis S et al. Evidence based public health: A review of the experience of the National Institute of Health and Clinical Excellence (NICE) of developing public health guidance in England. Social Science & Medicine 2010; 71: 1056-1062 11 Dixon-Woods M, Agarwal S, Jones D et al. Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Services Research & Policy 2005; 10: 45-53 12 Noyes J, Gough D, Lewin S et al. A research and development agenda for systematic reviews that ask complex questions about complex interventions. J Clin Epidemiol 2013; 66: 1262-1270 13 Ahmed F, Temte JL, Campos-Outcalt D et al. Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine 2011; 29: 9171-9176 13 Ständige Impfkommission (STIKO): Standardvorgehensweise (SOP) der STIKO für die systematische Entwicklung von Impfempfehlungen. 2011 abrufbar unter www.www.stiko.de 15 Guyatt GH, Oxman AD, Schunemann HJ et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64: 380-382 16 Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008; 336: 924-926 17 Schunemann HJ, Langer G, Meerpohl JJ et al. [The GRADE system: a prologue to the article series in the ZEFQ]. Das GRADE-System: Ein Prolog zur Artikelserie in der ZEFQ. Z Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2012; 106: 354-356 18 Koch J, Wiese-Posselt M, Remschmidt C et al. Background paper to the recommendation for routine rotavirus vaccination of infants in Germany. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013; 56: 957-984 19 Harder T, Remschmidt C, Falkenhorst G et al. Background paper to the revised recommendation for hepatitis B vaccination of persons at particular risk and for hepatitis B postexposure prophylaxis in Germany. [Hintergrundpapier zu den überarbeiteten STIKO-Empfehlungen für die Hepatitis-B-Indikationsimpfung und postexpositionelle Hepatitis-B-Prophylaxe]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013; 56: 1565-1576 20 Falkenhorst G, Harder T, Remschmidt C et al. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany. [Hintergrundpapier zur Empfehlung einer bevorzugten Anwendung von attenuiertem Influenza-Lebendimpfstoff bei 2- bis 6-jährigen Kindern in Deutschland]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013; 56: 1557-1564 21 Guyatt G, Oxman AD, Akl EA et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-394
